Transurethral plasmakinetic vaporization of prostate with enucleation technique in the treatment of benign prostatic hyperplasia(Report of 230 cases)

Objective:To evaluate the security and effectiveness of transurethral plasmakinetic vaporization of prostate (TUPKVP) with enucleation technique in the treatment of benign prostatic hyperplasia(BPH). Methods:All of 230 patients admitted to our clinic with symptomatic prostatic obstruction between 2005 and 2007, were included in this study. After surgery, the therapeutic outcome was evaluated using the International Prostate Symptom Score (IPSS), maximum urinary flow rate (Qmax) and long term complications were surveyed.Result:The operating time was 45~150 mins, with mean blood loses of (100±20) ml. The prostate gland excised weight approximately 12~90g, average (30±9) g.Twenty-three patients had bladder and two patients (0.8%) had an additional transurethral vaporization of prostate for postoperative heavy bleeding. All patients were followed by 2~24 months. The mean IPSS decreased from 27 to 5 after TUPKVP.Conclusions:TUPKVP with the enucleation technique has good clinical results with high efficacy and safety,and less blood loses in patients with BPH.